piperacillin--tazobactam-drug-combination and Gastritis

piperacillin--tazobactam-drug-combination has been researched along with Gastritis* in 2 studies

Other Studies

2 other study(ies) available for piperacillin--tazobactam-drug-combination and Gastritis

ArticleYear
Emphysematous Gastritis.
    The Journal of the American Osteopathic Association, 2019, Dec-01, Volume: 119, Issue:12

    Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Emphysema; Foreign Bodies; Gastritis; Humans; Male; Melena; Middle Aged; Pantoprazole; Piperacillin, Tazobactam Drug Combination; Tomography, X-Ray Computed

2019
Role Of Conservative Management In Emphysematous Gastritis.
    BMJ case reports, 2018, Feb-23, Volume: 2018

    Emphysematous gastritis (EG) is a rare disease of the stomach that is caused by gas-forming bacteria, and it can be lethal. There have been <70 reported cases in the English literature of this disease which carries a mortality rate up to 60%. Early recognition and treatment through conservative management have been a popular and successful choice in today's medicine. Studies have shown that surgical intervention does not confer a statistical benefit on mortality in this condition. We present another case of EG in a 33-year-old woman who was successfully managed conservatively.

    Topics: Adult; Anti-Bacterial Agents; Conservative Treatment; Emphysema; Female; Fluid Therapy; Gastric Mucosa; Gastritis; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tomography, X-Ray Computed; Vancomycin

2018